Literature DB >> 3348227

Sweetener content of common pediatric oral liquid medications.

E M Hill1, C M Flaitz, G R Frost.   

Abstract

The types and concentrations of sweeteners in common prescription liquid and chewable medications for pediatric use were determined by manufacturer survey. Oral-liquid and chewable antibiotic, antifungal, bronchodilator, antihistamine, anticonvulsant, and miscellaneous products were identified. The manufactures were asked by telephone the type and amount of sweeteners in their products. Two follow-up letters requested confirmation of the sweetener contents; manufacturers' approval for publication of the information was also requested by mail. Sweetener information on 160 preparations was obtained. For antibiotics such as ampicillin, amoxicillin, erythromycin ethylsuccinate, and penicillin VK, products from different manufacturers had a wide range of sucrose concentration (18%-80%). Only four antibiotic preparations were sucrose free. The bronchodilators and antihistamines contained either sucrose, sorbitol, or saccharin. The anticonvulsants contained 0%-60% sucrose. Health-care practitioners who prescribe or dispense oral liquid or chewable prescription drug products should know that products in a given category can vary in type and amount of sweetener.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348227

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  6 in total

Review 1.  Formulation Challenges and Strategies to Develop Pediatric Dosage Forms.

Authors:  Wedad A Malkawi; Enas AlRafayah; Mohammad AlHazabreh; Salam AbuLaila; Abeer M Al-Ghananeem
Journal:  Children (Basel)       Date:  2022-04-01

2.  Marketing Strategies Used to Promote Children's Medicine Sold on Internet Sites of Pharmaceutical Stores.

Authors:  Corey H Basch; Katherine J Roberts; Emily A Zagnit; Amairany Martinez
Journal:  J Community Health       Date:  2016-12

3.  Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.

Authors:  Hudson C Polonini; Sharlene L Silva; Thalyta R de Almeida; Marcos Antônio F Brandão; Anderson O Ferreira
Journal:  Eur J Hosp Pharm       Date:  2016-03-24

4.  Compatibility of proton pump inhibitors in a preservative-free suspending vehicle.

Authors:  Hudson C Polonini; Sharlene L Silva; Shirley Loures; Rachel Almy; Antoine Balland; Marcos Antônio F Brandão; Anderson O Ferreira
Journal:  Eur J Hosp Pharm       Date:  2016-11-25

5.  A modern view of excipient effects on bioequivalence: case study of sorbitol.

Authors:  M-L Chen; A B Straughn; N Sadrieh; M Meyer; P J Faustino; A B Ciavarella; B Meibohm; C R Yates; A S Hussain
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.580

Review 6.  Sweetener content and cariogenic potential of pediatric oral medications: A literature.

Authors:  Jehan Al Humaid
Journal:  Int J Health Sci (Qassim)       Date:  2018 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.